High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Saved in:
Bibliographic Details
Title: High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Authors: Cascinu, S.1 cascinu@yahoo.com, Scartozzi, M.1, Labianca, R.2, Catalano, V.3, Silva, R. R.4, Barni, S.5, Zaniboni, A.6, Angelo, A. D.7, Salvagni, S.7, Martignoni, G.8, Berardi, R.1, Graziano, F.9, Beretta, G. D.2, Franciosi, V.7
Source: British Journal of Cancer. 4/19/2004, Vol. 90 Issue 8, p1521-1525. 5p. 1 Diagram, 3 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00070920
DOI:10.1038/sj.bjc.6601752